Czech republic Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in czech republic, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Medical Equipment
Last published date:

Overview 

The health care sector is very active in the Czech Republic; although, domestic manufacturers are increasingly competitive. Most medical devices used in the Czech Republic are imported. Germany dominates the market and is followed by the United States. Other countries with notable healthcare imports to the Czech Republic in specific categories include Japan, China, Switzerland, and the United Kingdom. American products, particularly high-tech equipment, have a good reputation for quality. 

The Czech healthcare system is predominantly financed by the public sector through mandatory insurance contributions, private expenditures amount only around three percent. In 2022, Czech insurance companies spent $20.04 billion (CZK434.2bln). Most costs were covered by mandatory healthcare insurance and other public sources.  

The Czech Republic spends around 7.5 percent of its GDP on healthcare each year. The use of health services is among the highest in the OECD. This may be due to patients perceiving medical services as being “free of charge” although everyone must pay for insurance (according to the Czech Constitution, everyone is entitled to the best available care).  

There are 156 acute care hospitals, 37 after care hospitals, and 35 long term care facilities in the Czech Republic, ten of which are faculty hospitals directly managed by the Ministry of Health. Czech hospitals and clinics are eager to adopt new technologies and quality products to keep their services current. In this respect, the Czech Republic offers excellent opportunities for medical device companies. Moreover, eHealth and telemedicine have been discussed widely in the Czech Republic. The Czech government is looking to obtain EU funds to help introduce eHealth throughout the country. The Vysocina and Karlovy Vary regions have already introduced small-scale eHealth projects and ePrescription and eSicknote have been adopted countrywide.  

The Czech Republic is a popular destination for medical tourism. It is known for reasonably priced, high-quality treatments. Aesthetic medicine procedures, IVD treatments, obesity treatment and gynecological procedures are in high demand. 

                         Czech Trade Data (US$, thousands)

 

2020

2021

2022

2023 (Estimated)

Total Exports

841,079

990,116

1,052,047

 1,100,000

Total Imports

1,048,270

1,251,711

1,319,173

 1, 350,000

Imports from the US

188,622

230,354

254,219

 285,000

Units: $ thousands

Source:  Unofficial estimates (products including HS 9018, 9019, 9021, 9022), Czech Statistical Office

Leading Sub-Sectors

The best market opportunities exist for cutting-edge, high quality and technically sophisticated medical equipment, especially equipment that increases efficiency and reduces occupancy rates in hospitals. The following products have potential in the Czech market:   

  • Minimally invasive surgery (MIS) technologies 
  • Patient monitoring systems 
  • Telemedicine & eHealth 
  • Home-care equipment

Opportunities

Czech institutions are interested in partnering with U.S. companies, hospitals, and universities to create medical research partnerships. 

The Czech Republic plans to use European Union Recovery and Resilience Funds to finance some healthcare projects, with particular attention to oncology and eHealth.  

Resources  

U.S. Commercial Service Contact: Veronika.Novakova@trade.gov.  

 

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility